Ronald L. Moy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ronald L. Moy has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Edgar F. Fincher
Moy‐Fincher Medical Group, Los Angeles, California
10 shared publications- David J. Kouba
Division of Mohs Micrographic Surgery, Department of Dermatology, Henry Ford Health System, Detroit, Michigan
7 shared publications Diego E. Marra
All authors are affiliated with the David Geffen School of Medicine at UCLA and West Los Angeles VA Medical Center, Los Angeles, California
6 shared publicationsJulie Iwasaki
4 shared publicationsDavid J. Kouba
Department of Dermatology, The Henry Ford Health System, Detroit, Michigan
3 shared publications- Edgar F. Fincher
Moy‐Fincher Medical Group, UCLA Medical Plaza, Los Angeles, CA
3 shared publications
Latest Publications
- 8 February 2010
- Published by Cambridge University Press (CUP)
- p. 29-34
FILLERS: PAST, PRESENT, AND FUTURE
- 8 February 2010
- Published by Cambridge University Press (CUP)
- p. 29-34
FILLERS: PAST, PRESENT, AND FUTURE
- 8 February 2010
- Published by Cambridge University Press (CUP)
Office-Based Cosmetic Procedures and Techniques
In the last 20 years there has been an explosion of new cosmetic surgery procedures developed for a large base of office-based dermatologists, cosmetic surgeons, plastic and reconstructive surgeons, and otolaryngologists. Tricks and techniques are swapped across the globe, with practitioners in Europe, Asia, and North and South America. This is a practical, simple manual of those tricks and techniques, with input from specialists around the world. This book is aimed at practitioners who want to add new procedures to their scope of practice and learn new methods of application. A wide range of procedures, from fillers and neurotoxins to suture suspension and chemical peels, are covered here in a comparative format and accompanied by more than 200 color illustrations. In addition to detailing the procedures, chapters also cover anesthetic techniques and brands. This book is designed to be an easy and useful reference for the beginning practitioner or more senior physician.
- 8 February 2010
- Published by Cambridge University Press (CUP)
Office-Based Cosmetic Procedures and Techniques
In the last 20 years there has been an explosion of new cosmetic surgery procedures developed for a large base of office-based dermatologists, cosmetic surgeons, plastic and reconstructive surgeons, and otolaryngologists. Tricks and techniques are swapped across the globe, with practitioners in Europe, Asia, and North and South America. This is a practical, simple manual of those tricks and techniques, with input from specialists around the world. This book is aimed at practitioners who want to add new procedures to their scope of practice and learn new methods of application. A wide range of procedures, from fillers and neurotoxins to suture suspension and chemical peels, are covered here in a comparative format and accompanied by more than 200 color illustrations. In addition to detailing the procedures, chapters also cover anesthetic techniques and brands. This book is designed to be an easy and useful reference for the beginning practitioner or more senior physician.
- 1 December 2009
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 35 (12) , 1908-1917
Radiofrequency Ablation of Facial Nerve Branches Controlling Glabellar Frowning
Hyperdynamic activity of the corrugator supercilii and procerus muscles causes glabellar furrows. Recently, a novel radiofrequency device has become available that can effectively ablate the efferent nerves controlling corrugator and procerus contraction, producing clinical results that are similar to those of botulinum toxin. To assess the efficacy, longevity of effect, and side effects of the radiofrequency ablation device in the treatment of hyperdynamic glabellar furrows. Four probe entry points were used to access branches of the temporal and angular nerves. Seven and two ablations, respectively, were delivered to each temporal branch and angular nerve. Twenty-nine patients underwent bilateral radiofrequency ablation of temporal branches of the facial nerve and the angular nerves. Abrogation of glabellar furrowing was achieved in 90% of patients. No major adverse events were observed. All patients developed mild to moderate swelling, and nine patients (31%) developed purpura in the treated areas. Sixty-nine percent of patients had effects that lasted 4 months or longer, 41% had effects that lasted 6 months or longer, and 10% had effects lasting longer than 12 months. Radiofrequency ablation of efferent branches of the temporal and angular nerves effectively eliminates corrugator and procerus contraction and concomitant glabellar furrowing.
- 1 December 2009
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 35 (12) , 1908-1917
Radiofrequency Ablation of Facial Nerve Branches Controlling Glabellar Frowning
Hyperdynamic activity of the corrugator supercilii and procerus muscles causes glabellar furrows. Recently, a novel radiofrequency device has become available that can effectively ablate the efferent nerves controlling corrugator and procerus contraction, producing clinical results that are similar to those of botulinum toxin. To assess the efficacy, longevity of effect, and side effects of the radiofrequency ablation device in the treatment of hyperdynamic glabellar furrows. Four probe entry points were used to access branches of the temporal and angular nerves. Seven and two ablations, respectively, were delivered to each temporal branch and angular nerve. Twenty-nine patients underwent bilateral radiofrequency ablation of temporal branches of the facial nerve and the angular nerves. Abrogation of glabellar furrowing was achieved in 90% of patients. No major adverse events were observed. All patients developed mild to moderate swelling, and nine patients (31%) developed purpura in the treated areas. Sixty-nine percent of patients had effects that lasted 4 months or longer, 41% had effects that lasted 6 months or longer, and 10% had effects lasting longer than 12 months. Radiofrequency ablation of efferent branches of the temporal and angular nerves effectively eliminates corrugator and procerus contraction and concomitant glabellar furrowing.
- 2 March 2009
- Published by SAGE Publications in Archives of Facial Plastic Surgery
- Vol. 11 (2) , 77-83
Long-term Safety and Efficacy of a New Botulinum Toxin Type A in Treating Glabellar Lines
Objective To evaluate the long-term safety of repeated administrations of a new botulinum toxin type A (Reloxin; Medicis Pharmaceutical Corp, Scottsdale, Arizona) in the treatment of moderate to se...
- 2 March 2009
- Published by SAGE Publications in Archives of Facial Plastic Surgery
- Vol. 11 (2) , 77-83
Long-term Safety and Efficacy of a New Botulinum Toxin Type A in Treating Glabellar Lines
Objective To evaluate the long-term safety of repeated administrations of a new botulinum toxin type A (Reloxin; Medicis Pharmaceutical Corp, Scottsdale, Arizona) in the treatment of moderate to se...
- Open Access
- 1 March 2009
- Published by SAGE Publications in Archives of Facial Plastic Surgery
- Vol. 11 (2) , 77-83
Long-term Safety and Efficacy of a New Botulinum Toxin Type A in Treating Glabellar Lines
A generally accepted method for correcting the appearance of hyperkinetic lines of the face is the use of low doses of Clostridium botulinum toxin type A. One such product, Reloxin (Medicis Pharmaceutical Corp, Scottsdale, Arizona) (C botulinum type A toxin–hemagglutinin complex), has been in clinical use outside the United States for more than 15 years (marketed as botulinum neurotoxin [Dysport; Ipsen Biopharm Ltd, Wrexham, Wales]) for therapeutic indications such as dystonia and spasticity.1 It has been approved in more than 73 countries for various therapeutic indications and in 23 countries for the treatment of wrinkles (glabellar or hyperkinetic facial lines).1 In the United States, Reloxin has been under investigation for the treatment of glabellar lines since 2002. Many studies have been published in the peer-reviewed medical literature regarding the use of this biologic agent.2-14
- 1 March 2009
- Published by SAGE Publications in Archives of Facial Plastic Surgery
- Vol. 11 (2) , 77-83
Open AccessLong-term Safety and Efficacy of a New Botulinum Toxin Type A in Treating Glabellar Lines
A generally accepted method for correcting the appearance of hyperkinetic lines of the face is the use of low doses of Clostridium botulinum toxin type A. One such product, Reloxin (Medicis Pharmaceutical Corp, Scottsdale, Arizona) (C botulinum type A toxin–hemagglutinin complex), has been in clinical use outside the United States for more than 15 years (marketed as botulinum neurotoxin [Dysport; Ipsen Biopharm Ltd, Wrexham, Wales]) for therapeutic indications such as dystonia and spasticity.1 It has been approved in more than 73 countries for various therapeutic indications and in 23 countries for the treatment of wrinkles (glabellar or hyperkinetic facial lines).1 In the United States, Reloxin has been under investigation for the treatment of glabellar lines since 2002. Many studies have been published in the peer-reviewed medical literature regarding the use of this biologic agent.2-14
- 1 February 2009
- Vol. 8 (2) , 115-9
Rapid absorbing gut suture versus 2-octylethylcyanoacrylate tissue adhesive in the epidermal closure of linear repairs.
While a variety of epidermal wound closure techniques are utilized, there are few evidence based studies comparing techniques in head-to-head studies. To compare the aesthetic outcomes and wound healing properties of 2 epidermal closure mechanisms: 2-octylethylcyanoacrylate adhesive and rapid absorbing gut suture in skin closures. A total of 8 patients were enrolled in this randomized right-left comparative trial. Patients were randomized for epidermal closure with one half of their wounds (chest [n=6] and upper extremities [n=2]) with tissue adhesive and the contralateral with rapid absorbing gut suture. Three months following wound closure, overall cosmetic outcome was slightly greater on the half closed with rapid absorbing gut suture (mean=3.56) relative to the tissue adhesive (mean=3.19, P=.05). For dyspigmentation, the half of the scar treated with the suture had a better outcome (mean=3.50) relative to tissue adhesive (mean=2.75) (P<.05). All other variables (i.e., scar thickness, wound approximation, patient outcome, and preference) were highly equivalent. Both rapid absorbing gut suture and tissue adhesive appear to be highly efficacious techniques for epidermal closure. It appears that tissue adhesive may not be as effective in achieving optimal cosmesis for defects after Mohs micrographic surgery on the trunk and extremities in follow-up at 3 months.
- 1 February 2009
- Vol. 8 (2) , 115-9
Rapid absorbing gut suture versus 2-octylethylcyanoacrylate tissue adhesive in the epidermal closure of linear repairs.
While a variety of epidermal wound closure techniques are utilized, there are few evidence based studies comparing techniques in head-to-head studies. To compare the aesthetic outcomes and wound healing properties of 2 epidermal closure mechanisms: 2-octylethylcyanoacrylate adhesive and rapid absorbing gut suture in skin closures. A total of 8 patients were enrolled in this randomized right-left comparative trial. Patients were randomized for epidermal closure with one half of their wounds (chest [n=6] and upper extremities [n=2]) with tissue adhesive and the contralateral with rapid absorbing gut suture. Three months following wound closure, overall cosmetic outcome was slightly greater on the half closed with rapid absorbing gut suture (mean=3.56) relative to the tissue adhesive (mean=3.19, P=.05). For dyspigmentation, the half of the scar treated with the suture had a better outcome (mean=3.50) relative to tissue adhesive (mean=2.75) (P<.05). All other variables (i.e., scar thickness, wound approximation, patient outcome, and preference) were highly equivalent. Both rapid absorbing gut suture and tissue adhesive appear to be highly efficacious techniques for epidermal closure. It appears that tissue adhesive may not be as effective in achieving optimal cosmesis for defects after Mohs micrographic surgery on the trunk and extremities in follow-up at 3 months.
- 1 September 2008
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (9) , 1241-1244
Dual Nasal Sidewall and Lip Defects Combined into a Single Arcuate Advancement Flap
- 1 September 2008
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (9) , 1241-1244
Dual Nasal Sidewall and Lip Defects Combined into a Single Arcuate Advancement Flap
- 1 July 2008
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (7) , 963-967
Basal Cell Carcinoma Masquerading as the Chronic Ectropion of Lamellar Ichthyosis
- 1 July 2008
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (7) , 963-967
Basal Cell Carcinoma Masquerading as the Chronic Ectropion of Lamellar Ichthyosis
- 1 July 2008
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (7) , 963-967
Basal Cell Carcinoma Masquerading as the Chronic Ectropion of Lamellar Ichthyosis
- 1 July 2008
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 34 (7) , 963-967
Basal Cell Carcinoma Masquerading as the Chronic Ectropion of Lamellar Ichthyosis